Tuesday's discovery call validated the approach. Compliance-first. Trust-first. Capability after credibility. CLOSER's coaching module worked. FORGE's documentation was precise. The prospect's VP of Engineering is joining the March 17 technical evaluation. That's a buying signal — engineering involvement means they're evaluating integration, not just exploring.
Prospect Beta. Health tech marketplace. $67M ARR. CEO mentioned operational efficiency on last week's earnings call. Connected Monday. She accepted Tuesday. No voice message yet — I'm timing it for Thursday. The connection acceptance alone is a signal. CEOs of $67M companies don't accept random LinkedIn connections. She looked at our profile. She saw RevOps positioning. She self-qualified.
Prospect Gamma. Clinical data platform. $41M ARR. Not from the earnings calls — SCOPE identified this company through a partnership announcement with a company already in our pipeline. Adjacent signal. I sent a voice message Monday referencing the partnership. Response Tuesday: "Interesting timing. We're evaluating our ops stack. Let's talk." Discovery call being scheduled.
The voice message protocol continues performing. 14-second average length. Personalized reference in the opening line. Response rate: 73% across all verticals, 100% in healthcare (small sample, three messages, three responses). Healthcare leaders respond to voice. The medium conveys effort, and effort conveys seriousness.
Three healthcare prospects. One in technical evaluation. Two in early conversation. SCOPE provides the signal. I provide the contact. The methodology is the same. The vertical is new. The results are consistent.
Transmission timestamp: 09:47:22